Researcher Profile

Michael Arad

0000-0003-3723-7493

Publications

5,067

Citations

Co-Authors

Active Years

Publications

Journal Article Journal of the American Heart Association Aug 06, 2024

Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA‐HCM

Caroline J. Coats · Ahmad Masri · Michael E. Nassif · Roberto Barriales‐Villa +138 more

10.1161/jaha.124.035993 19 citations

Journal Article New England Journal of Medicine May 30, 2024

Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Martin S. Maron · Ahmad Masri · Michael E. Nassif · Roberto Barriales-Villa +29 more

10.1056/nejmoa2401424 259 citations

Journal Article European Heart Journal Aug 25, 2023

2023 ESC Guidelines for the management of cardiomyopathies

Elena Arbelo · Alexandros Protonotarios · Juan R Gimeno · Eloisa Arbustini +127 more

10.1093/eurheartj/ehad194 2,078 citations

Open Access Journal Article Journal of the American College of Cardiology Oct 01, 2023

International Consensus on Differential Diagnosis and Management of Patients With Danon Disease

Kimberly N. Hong · Emily A. Eshraghian · Michael Arad · Alessia Argirò +12 more

10.1016/j.jacc.2023.08.014 52 citations

Open Access Journal Article eLife Jun 28, 2022

SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients

Eric N Jimenez-Vazquez · Michael Arad · Álvaro Macías · Maria L Vera-Pedrosa +10 more

10.7554/elife.76576 25 citations

Journal Article European Heart Journal Apr 07, 2021

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Pablo García-Pavía · Claudio Rapezzi · Yehuda Adler · Michael Arad +20 more

10.1093/eurheartj/ehab072 1,011 citations

Journal Article The Lancet Sep 01, 2020

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto · Artur Oreziak · Roberto Barriales-Villa · Theodore P Abraham +83 more

10.1016/s0140-6736(20)31792-x 1,088 citations

Open Access Journal Article Molecular Genetics and Metabolism Mar 01, 2019

The effect of enzyme replacement therapy on clinical outcomes in female patients with Fabry disease – A systematic literature review by a European panel of experts

Dominique P. Germain · Michael Arad · Alessandro Burlina · Perry M. Elliott +8 more

10.1016/j.ymgme.2018.09.007 78 citations

Journal Article European Journal of Heart Failure Apr 16, 2019

Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology

Petar M. Seferovic · Marija Polovina · Johann Bauersachs · Michael Arad +43 more

10.1002/ejhf.1461 320 citations

Open Access Journal Article Cardiovascular Diabetology Aug 02, 2018

Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’

Maayan Waldman · Keren Cohen · Dor Yadin · Vadim Nudelman +7 more

10.1186/s12933-018-0754-4 137 citations

Publication Timeline

2024

2023

2022

2021

2020

2019

2018

Frequent Co-Authors

5×

5×

3×

3×

3×

3×

3×

3×

3×

3×